What is the revenue and EPS growth rate for Nu Skin Enterprises year over year?

What guidance did Nu Skin Enterprises's management provide for the next earnings period?

What were the key takeaways from Nu Skin Enterprises's earnings call?

What does Nu Skin Enterprises do and what are its main business segments?

What factors drove the changes in Nu Skin Enterprises's revenue and profit?

What is the market's earnings forecast for Nu Skin Enterprises next quarter?

Did Nu Skin Enterprises beat or miss consensus estimates last quarter?

What is Nu Skin Enterprises's latest dividend and current dividend yield?

- **Revenue and Profitability**: Q3 2025 revenue of $364 million (within guidance), EPS of 34 cents (high end of range), with gross margin improving to 70.5%.
- **Growth Drivers**: Latin America up 53% YoY; Prism IO device to reach 10,000+ units in Q4 2025; India pre-market opening with digital-first model.
- **Strategic Focus**: Shifting North America to intelligent wellness; RISE segment (LifeDNA) outperformed; cautious 2025 guidance reflects Prism IO and India launch risks.

**【Management Opening Remarks】**
- B.G. Hunt provided an overview of the call, emphasizing forward-looking statements and non-GAAP financial measures. The company highlighted its Q3 2025 results and strategic priorities for growth.

**【CEO Summary Section】**
- **Q3 2025 Financial Highlights**: Revenue of $364 million (within guidance), EPS of 34 cents (high end of guidance). Gross margin improved to 70.5%, driven by core business optimization.
- **Strategic Growth Drivers**: 
  - **Latin America Growth**: 53% YoY growth, showcasing success in emerging markets.
  - **Prism IO Launch**: A portable intelligent wellness device with 10,000+ units expected in Q4 2025, targeting 300,000+ subscribed customers by 2026.
  - **India Expansion**: Pre-market opening in Q4 2025, focusing on a digital-first model with localized products (e.g., SeraNu skincare line).
- **Segment Performance**: RISE segment (LifeDNA) exceeded expectations, while North America faced macroeconomic challenges but showed sequential improvement.

**【CFO Financial Commentary】**
- **Gross Margin Expansion**: 70.5% (vs. 70.1% YoY), driven by product mix optimization and cost control.
- **Cost Efficiency**: Selling expenses decreased to 35.8% of revenue (from 39% YoY), with core business selling expense at 41.7%.
- **Liquidity and Capital Allocation**: $252 million in cash, $20 million debt reduction, and $152.4 million remaining under share repurchase authorization.
- **Guidance Update**: Full-year 2025 revenue guidance narrowed to $1.48–$1.51 billion, with EPS of $3.15–$3.25.

**【Q&A Highlights】**
- **India Strategy**: Pre-market opening with a focus on digital infrastructure and localized products, aiming to learn and adapt to regional market dynamics.
- **North America Restructuring**: Shift from beauty to intelligent wellness with Prism IO, leveraging salesforce engagement and subscription-based models.
- **Southeast Asia Growth**: Sequential improvement driven by Pacific markets (e.g., Australia, New Zealand) and strong TR90 body transformation product performance.


Nu Skin Enterprises, Inc. (NUS) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

NUS

NUS fundamentals

You can ask Aime